United States · FDA National Drug Code directory
Mirtazapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72578-104_9ad8f423-a877-4069-8a11-92e1f934974a
- Product NDC
- 72578-104
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Mirtazapine
- Labeler
- Viona Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220807
- Source listing expiry
- 20261231
Source-listed ingredients
- MIRTAZAPINE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 BLISTER PACK in 1 CARTON (72578-104-84) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (72578-104-69) · 72578-104-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →